George H Conrades
CIK 1106231 · Executive Chairman · last filed 2025-06-20
George H Conrades is an Executive Chairman who has filed 124 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider sold $1.7M of ORCL on Jun 20, 2025. Across all open-market trades the lifetime net is −$16.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $77.4M across reported positions. 36 SEC filings were submitted jointly with IRONWOOD PHARMACEUTICALS INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ORCL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
FIFTH FLOOR
CAMBRIDGE, MA 02139
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ORCL | Director | 38,456 | $139.56 | $5.37M | -$19.61M | 29 | 2025-06-20 |
| Cyclerion Therapeutics, Inc. (CYCN) Delisted | Director | 31 | $23.52 | $729 | $0 | 6 | 2022-06-16 |
| AKAM | Director | 682,257 | $99.38 | $67.80M | $5.92M | 29 | 2018-05-22 |
| HOG | Director | 52,573 | $30.33 | $1.59M | -$2.75M | 13 | 2015-08-17 |
| IRWD | Director | 545,976 | $3.62 | $1.98M | $0 | 33 | 2015-06-05 |
| CAH | Director | 2,653 | $251.09 | $666.1K | $0 | 9 | 2008-11-19 |
Recent Filings
124 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-20 | ORCL | Sell (S) | −8,169 | -$1.74M | EDGAR |
| 2025-06-17 | ORCL | Notice (144) | −8,169 | -$1.74M | EDGAR |
| 2025-06-03 | ORCL | Mixed | +2,986 | $0 | EDGAR |
| 2025-04-23 | ORCL | Exer (M) | +22,500 | $978.5K | EDGAR |
| 2024-06-03 | ORCL | Mixed | +3,303 | $0 | EDGAR |
| 2024-05-06 | ORCL | Mixed | — | -$1.48M | EDGAR |
| 2024-05-03 | ORCL | Notice (144) | −20,000 | -$2.32M | EDGAR |
| 2024-05-02 | ORCL | Mixed | — | -$1.85M | EDGAR |
| 2024-05-01 | ORCL | Notice (144) | −25,000 | -$2.90M | EDGAR |
| 2023-11-13 | ORCL | Notice (144) | −2,325 | -$264.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.